Program Office

Centre Director – Jukka Lausmaa
Scientific Director – Pontus Blomberg
WP1 – Process development – Stefan Scheding
WP2 – Infrastructure for GMP manufacturing – Pontus Blomberg
WP3 – Quality control, shelf-life and logistics – Jim Lund
CCP1 – Legislation, regulatory aspects and ethics – Ann Novotny
CCP2 – Swedish ATMP challenges and opportunities – Kristina Kannisto
Industry representatives;
– Mohammad Bohlooly (AstraZeneca)
– Raimund Strehl (VERIGRAFT)
Coordinator – Paul Kingham
Communications – Heather Main